2010 BC Guide in Determining Fitness to Drive
2010 BC Guide in Determining Fitness to Drive 2010 BC Guide in Determining Fitness to Drive
RestrictionsRe-assessmentguidelinesPolicy rationaleNo restrictions are required.OSMV will re-assess annually.Severe hypoglycemia indicates a lack of glycemic control and the potential forfurther hypoglycemic episodes. Once control is re-established and drivingresumes, more stringent glucose monitoring guidelines are requiredtemporarily to mitigate the increased risk of hypoglycemia.104
11.14 Commercial drivers who have an episode of hypoglycemia unawarenessApplicationAssessmentguidelinesFitnessguidelinesOSMVdeterminationguidelinesConditionsThese guidelines apply to driver fitness determinations for commercialdrivers who have had an episode of hypoglycemia unawareness within theprevious year. If the hypoglycemia unawareness is persistent (i.e., the driverhas not regained awareness), see the guidelines under 11.15.Driver fitness determinations will be made by case managers.If further information is required, OSMV will request: a Doctor’s Report on Commercial Driver with Diabetes on Insulincompleted by the treating physician. To complete this form, theindividual must have the results of an HbA1C test taken within theprevious 3 months, and a Driver’s Report – Commercial Driver with Diabetes on Insulincompleted by the applicant.Individuals who have experienced an episode of hypoglycemia unawarenessmay not drive for a minimum of 3 months after the episode. After 3 months,they may drive if: they have provided their treating physician with a blood glucose log of atleast 4 readings per day for 30 days, in which less than 5% of thereadings are below 4.0 mmol/L their treating physician has indicated to OSMV that they have regainedglycemic awareness and have stable glycemic control, and OSMV hasdetermined that they are fit to resume driving, and they follow the blood glucose monitoring guidelines for individuals witha history of severe hypoglycemia.OSMV may find individuals fit to drive if: it has been at least 3 months since the episode of hypoglycemiaunawareness they have provided their treating physician with a blood glucose log of atleast 4 readings per day for 30 days, in which less than 5% of thereadings are below 4.0 mmol/L, and their treating physician has indicated that they have regained glycemicawareness and have stable glycemic control.OSMV will impose the following conditions on an individual who is foundfit to drive: you must report to OSMV and your physician if you have an episode ofsevere hypoglycemia or hypoglycemia unawareness you must test your blood glucose concentration immediately beforedriving and approximately every hour while driving, and you must not drive, or you must stop driving, when your blood glucoselevel falls below 6.0 mmol/L and you must not resume driving until yourblood glucose level has risen above 6.0 mmol/L after food ingestion.105
- Page 67 and 68: A driver fitness determination is a
- Page 69 and 70: Policy rationaleBecause individuals
- Page 71 and 72: 7.5.3 Generally, an individual whos
- Page 73 and 74: 7.6.2 In particular, the case manag
- Page 75 and 76: 7.8.3 Whether an individual can com
- Page 77 and 78: in order to be fit to drive, the ca
- Page 79 and 80: has the judgment and willingness to
- Page 81 and 82: Policy7.11.1 If a case manager or a
- Page 83 and 84: (e) the medical condition results i
- Page 85 and 86: 7.12 Communicating a decisionPolicy
- Page 87 and 88: 7.13 Determination proceduresThe fo
- Page 89 and 90: During the reconsideration, the adj
- Page 91 and 92: 8.3 Reconsideration proceduresThe f
- Page 93 and 94: Chapter 9:Introduction to the Medic
- Page 95 and 96: 9.4 Medical condition chapter templ
- Page 97 and 98: Private and commercial drivers who
- Page 99 and 100: Chapter 11: Diabetes - Hypoglycemia
- Page 101 and 102: PercentFigure 1 - Prevalence of Dia
- Page 103 and 104: neuropathy, nephropathy, cardiovasc
- Page 105 and 106: 11.7 Private and commercial drivers
- Page 107 and 108: 11.8 Private drivers with diabetes
- Page 109 and 110: 11.9 Commercial drivers with diabet
- Page 111 and 112: RestrictionsRe-assessmentguidelines
- Page 113 and 114: Policy rationaleSevere hypoglycemia
- Page 115 and 116: 11.12 Private drivers who have pers
- Page 117: 11.13 Commercial drivers who have a
- Page 121 and 122: 11.15 Commercial drivers who have p
- Page 123 and 124: PART B - HYPOGLYCEMIA11a. Has the p
- Page 125 and 126: Produce my glycemic log for my doct
- Page 127 and 128: Deep-vein thrombosisDeep-vein throm
- Page 129 and 130: Aneurysms less than 5 cm in diamete
- Page 131 and 132: GUIDELINES12.6 Private and commerci
- Page 133 and 134: 12.7 Private drivers who have an an
- Page 135 and 136: 12.9 Commercial drivers who have an
- Page 137 and 138: Chapter 13: Musculoskeletal Conditi
- Page 139 and 140: ConditionType of drivingimpairment
- Page 141 and 142: GUIDELINES13.6 Private and commerci
- Page 143 and 144: ConditionsRestrictionsRe-assessment
- Page 145 and 146: 14.3 Chronic renal disease and adve
- Page 147 and 148: GUIDELINES14.6 Private and commerci
- Page 149 and 150: 14.8 Private drivers with end-stage
- Page 151 and 152: 14.10 Private and commercial driver
- Page 153 and 154: Level ofImpairmentMildlyImpairedMod
- Page 155 and 156: GUIDELINES15.6 Private and commerci
- Page 157 and 158: 15.8 Commercial drivers with modera
- Page 159 and 160: 15.10 Commercial drivers with sever
- Page 161 and 162: Policy rationaleDrivers who require
- Page 163 and 164: Chapter 16: Vestibular DisordersBAC
- Page 165 and 166: One study identified that 32.5% of
- Page 167 and 168: ConditionType ofdrivingimpairmentan
RestrictionsRe-assessmentguidel<strong>in</strong>esPolicy rationaleNo restrictions are required.OSMV will re-assess annually.Severe hypoglycemia <strong>in</strong>dicates a lack of glycemic control and the potential forfurther hypoglycemic episodes. Once control is re-established and driv<strong>in</strong>gresumes, more str<strong>in</strong>gent glucose moni<strong>to</strong>r<strong>in</strong>g guidel<strong>in</strong>es are requiredtemporarily <strong>to</strong> mitigate the <strong>in</strong>creased risk of hypoglycemia.104